Skip to content

Development of a Robotic Ankle Assist Device

Development of a Robotic Ankle Assist Device to Improve Mobility in Individuals With Movement Disorders

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04516343
Enrollment
31
Registered
2020-08-18
Start date
2020-11-01
Completion date
2024-08-31
Last updated
2025-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

The overall objectives of this work is to establish feasibility of a robotic ankle assist device (RAAD) to improve mobility in free-living settings and to establish the RAAD as an effective tool to provide increased dose and precision of targeted ankle therapy. The first specific goal is to assess the benefits of repeated gait training with RAAD assistance. Individuals with CP will participate in a 4-week assistance intervention and mobility outcomes will be quantified pre and post intervention. The second specific goal is to separately assess the benefits of repeated gait training with RAAD resistance. Individuals with CP will participate in a 4-week resistance intervention and mobility outcomes will be quantified pre and post intervention. Assessed separately, it is hypothesized that both assistance and resistance training will improve mobility outcomes.

Interventions

DEVICERobotic Ankle Assist Device (RAAD)

The RAAD (Robotic Ankle Assist Device) is an intelligent, powered ankle device designed to increase independence, mobility, and deliver gait training to children with movement disorders, such as CP

Sponsors

Northern Arizona University
CollaboratorOTHER
Gillette Children's Specialty Healthcare
CollaboratorOTHER
Shirley Ryan AbilityLab
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
BiOMOTUM, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This study has two experiments. In experiment I, participants will be recruited to complete gait training with the RAAD under assistance mode. In experiment two, participants will be recruited to complete gait training with the RAAD under resistance mode.

Eligibility

Sex/Gender
ALL
Age
8 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

Diagnosis of cerebral palsy. Any sex, race, ethnicity or socioeconomic status. GMFCS level I, II, or II. Ability to walk for at least 6 minutes (assisted or unassisted). Age between 8-18 years. Height/weight/BMI between the 5th - 95th percentile of children with CP. Able to understand and follow simple directions. Able to complete 5 heel raises with minimal assistance (balance only). At least 20 degrees of passive ankle plantar flexion range of motion.

Exclusion criteria

Knee extension or ankle dorsiflexion contractures greater than 15 degrees. Health condition or diagnosis other than CP that would affect safe participation. Orthopedic surgery completed in the prior 12-months. Current enrollment in a conflicting research study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Preferred Walking Speedbaseline and post intervention at 6 minutesHow fast someone prefers to walk

Secondary

MeasureTime frameDescription
Change in 6MWT6 minutes pre/postChange in Six-minute walk test, which is the total distance walked over a 6 minute period.
Change in Gait Kinetics6 minutes pre/postChange in Average knee angle across stance phase measured in degrees
Change in COTbaseline and post interventionChange in Metabolic cost of transport
Change in Gross Motor Function Measure Scale 6620 minutes pre/postChange in Gross motor function measure scale 66, min score = 0, max score = 66, high score is better. Unit of measure = Scores on a scale.
Change in Fast Walking Speedbaseline and post interventionHow fast participants prefer to walk quickly (m/s)
Change in Step Lengthbaseline and post interventionStep length during walking

Countries

United States

Participant flow

Participants by arm

ArmCount
Therapist Supervised Assistance Training
Assistance training with the RAAD under therapist supervision. Robotic Ankle Assist Device (RAAD): The RAAD (Robotic Ankle Assist Device) is an intelligent, powered ankle device designed to increase independence, mobility, and deliver gait training to children with movement disorders, such as CP
12
Therapist Supervised Resistance Training
Resistance training with the RAAD under therapist supervision. Robotic Ankle Assist Device (RAAD): The RAAD (Robotic Ankle Assist Device) is an intelligent, powered ankle device designed to increase independence, mobility, and deliver gait training to children with movement disorders, such as CP
19
Total31

Baseline characteristics

CharacteristicTherapist Supervised Assistance TrainingTotalTherapist Supervised Resistance Training
Age, Continuous13.6 years
STANDARD_DEVIATION 3.3
13.4 years
STANDARD_DEVIATION 3.6
13.2 years
STANDARD_DEVIATION 3.9
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants11 Participants9 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants20 Participants10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants4 Participants2 Participants
Race (NIH/OMB)
Black or African American
3 Participants5 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants7 Participants6 Participants
Race (NIH/OMB)
White
6 Participants15 Participants9 Participants
Region of Enrollment
United States
12 participants31 participants19 participants
Sex: Female, Male
Female
6 Participants14 Participants8 Participants
Sex: Female, Male
Male
6 Participants17 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 16
other
Total, other adverse events
3 / 120 / 16
serious
Total, serious adverse events
0 / 120 / 16

Outcome results

Primary

Change in Preferred Walking Speed

How fast someone prefers to walk

Time frame: baseline and post intervention at 6 minutes

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in Preferred Walking Speed0.09 m/sStandard Deviation 0.13
Therapist Supervised Resistance TrainingChange in Preferred Walking Speed0.13 m/sStandard Deviation 0.14
Secondary

Change in 6MWT

Change in Six-minute walk test, which is the total distance walked over a 6 minute period.

Time frame: 6 minutes pre/post

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in 6MWT46 mStandard Deviation 53.7
Therapist Supervised Resistance TrainingChange in 6MWT48.4 mStandard Deviation 74.2
Secondary

Change in COT

Change in Metabolic cost of transport

Time frame: baseline and post intervention

Population: 6 participants were unable to complete this outcomes measure test because of the metabolic face mask.

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in COT-0.06 J/kg/mStandard Deviation 0.13
Therapist Supervised Resistance TrainingChange in COT-0.01 J/kg/mStandard Deviation 0.11
Secondary

Change in Fast Walking Speed

How fast participants prefer to walk quickly (m/s)

Time frame: baseline and post intervention

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in Fast Walking Speed0.06 m/sStandard Deviation 0.18
Therapist Supervised Resistance TrainingChange in Fast Walking Speed0.18 m/sStandard Deviation 0.21
Secondary

Change in Gait Kinetics

Change in Average knee angle across stance phase measured in degrees

Time frame: 6 minutes pre/post

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in Gait Kinetics-1.62 degreesStandard Deviation 2.05
Therapist Supervised Resistance TrainingChange in Gait Kinetics-2.00 degreesStandard Deviation 6.89
Secondary

Change in Gross Motor Function Measure Scale 66

Change in Gross motor function measure scale 66, min score = 0, max score = 66, high score is better. Unit of measure = Scores on a scale.

Time frame: 20 minutes pre/post

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in Gross Motor Function Measure Scale 661.43 scores on a scaleStandard Deviation 3.1
Therapist Supervised Resistance TrainingChange in Gross Motor Function Measure Scale 661.56 scores on a scaleStandard Deviation 2.032
Secondary

Change in Step Length

Step length during walking

Time frame: baseline and post intervention

ArmMeasureValue (MEAN)Dispersion
Therapist Supervised Assistance TrainingChange in Step Length0.082 mStandard Deviation 0.184
Therapist Supervised Resistance TrainingChange in Step Length0.072 mStandard Deviation 0.142

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026